Gene Therapy for Muscular Dystrophies
- 1 January 2001
- journal article
- Published by Springer Nature in BioDrugs
- Vol. 15 (10) , 635-644
- https://doi.org/10.2165/00063030-200115100-00001
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Gene Therapy for Muscle and Connective Tissue DiseasesMolecular Therapy, 2001
- Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 DiseaseScience, 2000
- Effective adenovirus-mediated gene expression in adult murine skeletal muscleMuscle & Nerve, 1999
- rAAV vector-mediated sarcogylcan gene transfer in a hamster model for limb girdle muscular dystrophyGene Therapy, 1999
- Efficient Utrophin Expression Following Adenovirus Gene Transfer in Dystrophic MuscleBiochemical and Biophysical Research Communications, 1998
- Bacterial β‐galactosidase and human dystrophin genes are expressed in mouse skeletal muscle fibers after ballistic transfectionFEBS Letters, 1997
- Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2ACell, 1995
- Myoblast transfer in duchenne muscular dystrophyAnnals of Neurology, 1993
- Human dystrophin expression in mdx mice after intramuscular injection of DNA constructsNature, 1991
- Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individualsCell, 1987